811 related articles for article (PubMed ID: 17145886)
21. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
[TBL] [Abstract][Full Text] [Related]
22. PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1.
Ouyang W; Li J; Zhang D; Jiang BH; Huang DC
J Cell Biochem; 2007 Jul; 101(4):969-78. PubMed ID: 17370311
[TBL] [Abstract][Full Text] [Related]
23. Abrogation of p53 by its antisense in MCF-7 breast carcinoma cells increases cyclin D1 via activation of Akt and promotion of cell proliferation.
Chhipa RR; Kumari R; Upadhyay AK; Bhat MK
Exp Cell Res; 2007 Nov; 313(19):3945-58. PubMed ID: 17935714
[TBL] [Abstract][Full Text] [Related]
24. Functional activity of ectopically expressed estrogen receptor is not sufficient for estrogen-mediated cyclin D1 expression.
Planas-Silva MD; Donaher JL; Weinberg RA
Cancer Res; 1999 Oct; 59(19):4788-92. PubMed ID: 10519385
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
[TBL] [Abstract][Full Text] [Related]
26. Growth-inhibitory effects of a beta-glucan from the mycelium of Poria cocos on human breast carcinoma MCF-7 cells: cell-cycle arrest and apoptosis induction.
Zhang M; Chiu LC; Cheung PC; Ooi VE
Oncol Rep; 2006 Mar; 15(3):637-43. PubMed ID: 16465424
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: lack of correlation between inhibition of cell growth and MAP kinase activation.
Wieder R; Fenig E; Wang H; Wang Q; Paglin S; Menzel T; Gabrilove J; Fuks Z; Yahalom J
J Cell Physiol; 1998 Dec; 177(3):411-25. PubMed ID: 9808150
[TBL] [Abstract][Full Text] [Related]
28. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
Yang C; Klein EA; Assoian RK; Kazanietz MG
Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
[TBL] [Abstract][Full Text] [Related]
29. The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer.
Lo TL; Yusoff P; Fong CW; Guo K; McCaw BJ; Phillips WA; Yang H; Wong ES; Leong HF; Zeng Q; Putti TC; Guy GR
Cancer Res; 2004 Sep; 64(17):6127-36. PubMed ID: 15342396
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
Ishii Y; Pirkmaier A; Alvarez JV; Frank DA; Keselman I; Logothetis D; Mandeli J; O'Connell MJ; Waxman S; Germain D
J Natl Cancer Inst; 2006 Sep; 98(17):1238-47. PubMed ID: 16954476
[TBL] [Abstract][Full Text] [Related]
31. cFos is critical for MCF-7 breast cancer cell growth.
Lu C; Shen Q; DuPré E; Kim H; Hilsenbeck S; Brown PH
Oncogene; 2005 Sep; 24(43):6516-24. PubMed ID: 16027729
[TBL] [Abstract][Full Text] [Related]
32. Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens.
Pacilio C; Germano D; Addeo R; Altucci L; Petrizzi VB; Cancemi M; Cicatiello L; Salzano S; Lallemand F; Michalides RJ; Bresciani F; Weisz A
Cancer Res; 1998 Mar; 58(5):871-6. PubMed ID: 9500441
[TBL] [Abstract][Full Text] [Related]
33. Thrombin stimulates RPE cell proliferation by promoting c-Fos-mediated cyclin D1 expression.
Parrales A; Palma-Nicolás JP; López E; López-Colomé AM
J Cell Physiol; 2010 Feb; 222(2):302-12. PubMed ID: 19847806
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
Balasenthil S; Barnes CJ; Rayala SK; Kumar R
FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330
[TBL] [Abstract][Full Text] [Related]
35. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
36. Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1.
Yde CW; Issinger OG
Int J Oncol; 2006 Dec; 29(6):1397-404. PubMed ID: 17088977
[TBL] [Abstract][Full Text] [Related]
37. BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.
Nakuci E; Mahner S; Direnzo J; ElShamy WM
Exp Cell Res; 2006 Oct; 312(16):3120-31. PubMed ID: 16860316
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
39. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells.
Gallegos A; Gasdaska JR; Taylor CW; Paine-Murrieta GD; Goodman D; Gasdaska PY; Berggren M; Briehl MM; Powis G
Cancer Res; 1996 Dec; 56(24):5765-70. PubMed ID: 8971189
[TBL] [Abstract][Full Text] [Related]
40. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
